Clinical Trial Update: L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates that L-cysteine may prevent stomach exposure to carcinogenic acetaldehyde, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Gastritis
• Gastritis

Drugs mentioned

• L-cysteine (L-cysteine)

Snippet

Sponsor: Per Hellström | Conditions: Gastritis, Atrophic | Phase 2 | Status: COMPLETED